SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-17-000253
Filing Date
2017-12-11
Accepted
2017-12-11 08:51:18
Documents
2
Effectiveness Date
2017-12-11

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1084
2 ocrx-form25.txt EX-99.25 103
  Complete submission text file 0001354457-17-000253.txt   2930
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 6504750158
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 001-35119 | Film No.: 171248526
SIC: 2834 Pharmaceutical Preparations

Mailing Address Office of General Counsel 805 King Farm Blvd. ROCKVILLE MD 20850
Business Address One Liberty Plaza New York NY 10006 301-978-4144
The Nasdaq Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE